Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

Common types of non-scarring hair loss have various causes and treatments, but more effective solutions are needed.

A clinically suspected melanoma appeared benign under the microscope but was confirmed by specific tests and a rare mutation.

The document explains various skin conditions and their treatments.

No treatment fully prevents hair loss from chemotherapy yet.

Melatonin may reduce skin damage caused by X-rays in rats.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

CD10 and CD34 levels change during hair development and different hair growth stages, which could be important for hair regeneration treatments.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.

New markers and pathways have been found in skin tumors, helping better understand and diagnose them.

No CD44 in alopecia areata, present in normal and androgenetic alopecia.

Ingenol mebutate gel changes gene expression related to skin development and immune response in actinic keratosis.

A woman with hair loss had a benign sweat duct tumor found during a scalp biopsy.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

Some plant-derived compounds may help with hormonal conditions, but more research is needed to confirm their effectiveness.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

Ultraviolet rays damage hair, smoking may cause hair loss, and good nutrition is important for hair health, but genetics mainly decide hair thickness.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Keratin is crucial for keeping skin cells healthy and its changes can lead to diseases and affect cell behavior.

The document concludes that individualized treatment for malignant epithelial tumors is necessary and more research on metastatic squamous cell carcinoma treatments is needed.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

The gene HDC is important for the development of hair follicles in newborn mice.

Women using hair relaxers with alopecia had lower zinc levels, suggesting zinc deficiency might contribute to hair loss.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

Activating β-catenin increases melanocytes and decreases Schwann cells.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."